Heterotopic bone formation induced by bone morphogenetic protein signaling: Fibrodysplasia ossificans progressiva

Journal of Oral Biosciences

Volumn 52, Issue 1, 2010, Pages 33-41

  Katagiri, Takenobu ^a,b  

^a Research Center for Genomic Medicine   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Genetic disease; Receptor; Signal transduction

Indexed keywords

EID: 77954143494     PISSN: 13490079     EISSN: None     Source Type: Journal    
DOI: 10.2330/joralbiosci.52.33     Document Type: Review

References (32)

1. Shapiro, F.: Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur. Cell. Mater. 15 :53-76, 2008. (Pubitemid 351958405)
2. Kronenberg, H.M.:The role of the perichondrium in fetal bone development. Ann. NY Acad. Sci. 1116:59-64, 2007. (Pubitemid 350274341)
3. Katagiri, T., Suda, T. and Miyazono, K.:The bone morphogenetic proteins. In:The TGF-b family. (eds. Derynck, R. and Miyazono, K), pp.121-149, Cold Spring Harbor Laboratory Press, New York, 2008.
4. Dean, D.B., Watson, J.T., Moed, B.R. and Zhang, Z.:Role of bone morphogenetic proteins and their antagonists in healing of bone fracture. Front Biosci. 14:2878-2888, 2009.
5. Urist, M.R.Bone:formation by autoinduction. Science 150(698)893-899, 1965.
6. Urist, M.R. and Strates, B.S.:Bone morphogenetic protein. J. Dent. Res. 50:1392-1406, 1971.
7. Kaplan, F.S., Tabas, J.A. and Zasloff, M.A.:Fibrodysplasia ossificans progressiva:a clue from the fly? Calcif. Tissue Int. 47:117-125, 1990. (Pubitemid 20238176)
8. Kaplan, F.S., Shen, Q., Lounev, V., Seemann, P., Groppe, J., Katagiri, T., Pignolo, R.J. and Shore, E.M.: Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J. Bone Miner. Metab. 26:521-530, 2008.
9. Shore, E.M., Xu, M., Feldman, G.J., Fenstermacher, D.A., Cho, T.J., Choi, I.H., Connor, J.M., Delai, P., Glaser, D.L., LeMerrer, M., Morhart, R., Rogers, J. G., Smith, R., Triffitt, J.T., Urtizberea, J.A., Zasloff, M., Brown, M.A. and Kaplan, F. S.:A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38:525-527, 2006.
10. Fukuda, T., Kohda, M., Kanomata, K., Nojima, J., Nakamura, A., Kamizono, J., Noguchi, Y., Iwakiri, K., Kondo, T., Kurose, J., Endo, K., Awakura, T., Fukushi, J., Nakashima, Y., Chiyonobu, T.,Kawara, A., Nishida, Y., Wada, I., Akita, M., Komori, T., Nakayama, K., Nanba, A., Maruki, Y., Yoda, T., Tomoda, H., Yu, P. B., Shore, E. M., Kaplan, F. S., Miyazono, K., Matsuoka, M., Ike-buchi, K., Ohtake, A., Oda, H., Jimi, E., Owan, I., Okazaki, Y. and Katagiri, T.:Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J. Biol. Chem. 284:7149-7156, 2009.
11. Sampath, T.K. and Reddi, A.H.:Homology of bone: inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proc. Natl. Acad. Sci USA 80:6591-6595, 1983. (Pubitemid 14240141)
12. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A. and Suda, T.:Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127 (6 Pt 1):1755-1766, 1994. (Pubitemid 24380911)
13. Miyazono, K., Maeda, S. and Imamura, T.:BMP receptor signaling :transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16:251-263, 2005. (Pubitemid 40910315)
14. Wieser, R., Wrana, J. L. and Massague, J.:GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J. 14:2199-2208, 1995.
15. Maeno, M., Ong, R. C., Suzuki, A., Ueno, N. and Kung, H. F.:A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm : roles of animal pole tissue in the development of ventral mesoderm. Proc. Natl. Acad. (Pubitemid 24328976)
16. Suzuki, A., Thies, R. S., Yamaji, N., Song, J. J., Wozney, J. M., Murakami, K. and Ueno, N.:A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc. Natl. Acad. Sci. USA 91:10255-10259, 1994. (Pubitemid 24328975)
17. Qin, B. Y., Chacko, B. M., Lam, S. S., de Caestecker, M. P., Correia, J. J. and Lin, K.:Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell 8:1303-1312, 2001. (Pubitemid 34085001)
18. Kaplan, F. S., Xu, M., Seemann, P., Connor, J. M., Glaser, D. L., Carroll, L., Delai, P., Fastnacht-Urban, E., Forman, S. J., Gillessen-Kaesbach, G., Hoover-Fong, J., Koster, B., Pauli, R. M., Reardon, W., Zaidi, S. A., Zasloff, M., Morhart, R., Mundlos, S., Groppe, J. and Shore, E. M.:Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum. Mutat. 30:379-390, 2009.
19. Xu, M. Q., Feldman, G., Le Merrer, M., Shugart, Y. Y., Glaser, D. L., Urtizberea, J. A., Fardeau, M., Connor, J. M., Triffitt, J., Smith, R., Shore, E. M. and Kaplan, F. S.:Linkage exclusionand mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP) Clin. Genet. 58:291-298, 2000.
20. Semonin, O., Fontaine, K., Daviaud, C., Ayuso, C. and Lucotte, G.:Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am. J. Med. Genet. 102:314-317, 2001. (Pubitemid 32778014)
21. Feldman, G., Li, M., Martin, S., Urbanek, M., Urtizberea, J. A., Fardeau, M., LeMerrer, M., Connor, J. M., Triffitt, J., Smith, R., Muenke, M., Kaplan, F. S. and Shore, E. M.:Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. Am. J. Hum. Genet. 66:128-135, 2000. (Pubitemid 30481475)
22. Nakajima, M., Haga, N., Takikawa, K., Manabe, N., Nishimura, G. and Ikegawa, S.:The ACVR1 617G A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. J. Hum. Genet. 52:473-475, 2007. (Pubitemid 46669303)
23. Fiori, J. L., Billings, P. C., de la Pena, L. S., Kaplan, F. S. and Shore, E. M.:Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva(FOP). J. Bone Miner. Res. 21:902-909, 2006. (Pubitemid 43787997)
24. Furuya, H., Ikezoe, K., Wang, L., Ohyagi, Y., Motomura, K., Fujii, N., Kira, J. and Fukumaki, Y.:A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am. J. Med. Genet. A 146 A:459-463, 2008. (Pubitemid 351206817)
25. Petrie, K. A., Lee, W. H., Bullock, A. N., Pointon, J. J., Smith, R., Russell, R. G., Brown, M. A., Wordsworth, B. P. and Triffitt, J. T.:Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. PLoS One 4 : e5005, 2009.
26. Bocciardi, R., Bordo, D., Di Duca, M., Di Rocco, M. and Ravazzolo, R.:Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva:confirmations and advancements. Eur. J. Hum. Genet. 17:311-318, 2009.
27. Groppe, J. C., Shore, E. M. and Kaplan, F. S.:Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin. Orthop. Relat. Res. 462:87-92, 2007. (Pubitemid 47367848)
28. Lounev, V. Y., Ramachandran, R., Wosczyna, M. N., Yamamoto, M., Maidment, A. D., Shore, E. M., Glaser, D. L., Goldhamer, D. J. and Kaplan, F. S.:Identification of progenitor cells that contribute to heterotopic skeletogenesis. J. Bone Joint Surg. Am. 91:652- 663, 2009.
29. Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D. and Peterson, R. T.:Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4:33-41, 2008. (Pubitemid 350273653)
30. Yu, P. B., Deng, D. Y., Lai, C. S., Hong, C. C., Cuny, G. D., Bouxsein, M. L., Hong, D. W., McManus, P. M., Katagiri, T., Sachidanandan, C., Kamiya, N., Fukuda, T., Mishina, Y., Peterson, R. T. and Bloch, K. D.: BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat. Med. 14:1363-1369, 2008.
31. Shafritz, A. B., Shore, E. M., Gannon, F. H., Zasloff, M. A., Taub, R., Muenke, M. and Kaplan, F. S.:Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N. Engl. J. Med. 335:555-561, 1996. (Pubitemid 26272310)
32. Kaplan, F. S., Glaser, D. L., Shore, E. M., Pignolo, R. J., Xu, M., Zhang, Y., Senitzer, D., Forman, S. J. and Emerson, S. G.:Hematopoietic stem-cell contribution to ectopic skeletogenesis. J. Bone Joint Surg. Am. 89:347-357, 2007. (Pubitemid 46214354)